This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions to: HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin 2, Tel: +353 1 6764971, Fax:+353 1 6762517, Website: www.hpra.ie, Email: medsafety@hpra.ie. Adverse events should also be reported to A. Menarini Pharmaceuticals Ireland Ltd. Phone no: 01 284 6744, Email: medinfo@menarini.ie.
Quality: point of departure and arrival for our drugs.
READ MORE »
The Menarini Group has companies located almost all over the world.
Constant commitment to new drug research.
10 core values have influenced the progress of our group.